Polatuzumab Vedotinpiiq for Injection: Innovations in Lymphoma Therapy
The treatment of lymphoma has seen significant advancements in recent years. Polatuzumab vedotinpiiq for injection stands at the forefront. This innovative therapy targets CD79b, a protein prevalent on B-cells, including those in malignant lymphomas. By conjugating an anti-CD79b monoclonal antibody with a potent cytotoxic agent, polatuzumab vedotinpiiq delivers targeted destruction of cancerous cells while sparing …
Polatuzumab Vedotinpiiq for Injection: Innovations in Lymphoma Therapy Read More »